Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
When more is more: Increased levels of wild-type and mutant RIT1 promote oncogenesis
From the Berger Lab, Human Biology Division
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
MYCN drives the development of chemoresistance in small cell lung cancer
From the MacPherson lab, Human Biology Division
Comparing sexual quality of life among survivors of prostate, bladder, colorectal, and lung cancer
From the Ramsey Group, Public Health Sciences Division
Lessons from cancer patients in the time of coronavirus
For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude and dancing help.
Largest single-year drop in cancer death rates continues encouraging trend
Stat reflects decrease in deaths from top 4 cancers; masks lack of progress in others
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy